Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
NBIX

Neurocrine Biosciences Inc. (NBIX)

NASDAQ
$162.74
-$3.11
(-1.87%)
Previous Close: ⁦$165.92⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Neurocrine Biosciences Inc. (NBIX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $162.74, with a market capitalization of $16.73B and a P/E ratio of 23.91. Over the past 52 weeks, its price has ranged from $122.14 to $186.12. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$16.73B

$165.00

$167.60

$161.51

$165.92

1.13M

1.32M

23.91

$186.12

$122.14

--

2026-09-30

Neurocrine Biosciences Inc. (NBIX) Latest Closing Stock Price

Neurocrine Biosciences Inc. (NBIX) last closed at $162.74 as of 2026-11-19 00:31:00, down 1.87% ($3.11) from the previous close of $165.92.

During the latest regular trading session, NBIX traded between $161.51 and $167.60, with a volume of 1.13M shares. The closing price was near the lower end and near the middle of its 52-week range.

Neurocrine Biosciences Inc. (NBIX) 7-Day Stock Price Change

Over the past seven days, Neurocrine Biosciences Inc. (NBIX) moved from $168.86 to $162.74, representing a decline of 3.62% ($6.12).

The stock traded between $161.51 and $174.59 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 1.28 million shares, down versus the previous seven-day period, indicating lower trading activity.

NBIX 52-Week Price Position

Position in Range: 63.5%

52W Low$122.14
52W High$186.12

NBIX is currently trading at $162.74, placing it 63.5% of the way from its 52-week low of $122.14 to its 52-week high of $186.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Neurocrine Biosciences Inc. (NBIX)?

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Neurocrine Biosciences Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
2,500
Exchange
NASDAQ
Company Website

NBIX News

Latest news related to Neurocrine Biosciences Inc. and NBIX stock.

  • Benzinga

    Morgan Stanley Maintains Equal-Weight on Neurocrine Biosciences, Raises Price Target to $191

    Morgan Stanley analyst Jeffrey Hung maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Equal-Weight and raises the price target from $185 to $191.

    Read Full Article
  • Massive

    GLP-1 RAs & Incretin-based Therapies Competitive Landscape Analysis: Key Developments by 200+ Companies Shaping the Treatment Landscape | DelveInsight

    DelveInsight released a comprehensive competitive landscape report on GLP-1 receptor agonists and incretin-based therapies, covering 200+ pipeline drugs from 180+ active players. The report highlights approved drugs like MOUNJARO (tirzepatide) and OZEMPIC (semaglutide), with 30+ therapies in late-stage development and 60+ in mid/early stages. Key indications include obesity, type 2 diabetes, and cardiovascular outcomes. Recent developments include positive Phase III results for retatrutide, survodutide, and other dual/triple agonists from major pharmaceutical companies.

    Read Full Article

Ways to Trade NBIX at MEXC

NBIX MEXC RealStocks

Own real NBIX shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Neurocrine Biosciences Inc. (NBIX) Stock on MEXC

Eligible investors can buy real shares of Neurocrine Biosciences Inc. (NBIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for NBIX and Place Your Order
Step 3: Search for NBIX and Place Your Order
Open the RealStocks trading page and search for NBIX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Neurocrine Biosciences Inc. (NBIX) stock price today?
Neurocrine Biosciences Inc. (NBIX) is currently trading at $162.74, down 1.87% ($3.11) from the previous close of $165.92. Intraday prices update in real time during regular trading hours.
2.Is NBIX stock going up or down today?
As of 2026-11-19 00:31:00, NBIX is trading at $162.74, down 1.87% ($3.11) from its previous close of $165.92. The stock has traded between $161.51 and $167.60 during today’s regular session. Past price movements do not guarantee future results.
3.What is NBIX pre-market price?
As of 2026-11-19 00:31:00, NBIX is trading at $164.42 in pre-market trading, down 0.90% ($1.50) from the previous close of $165.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is NBIX after-hours price?
As of 2026-11-19 00:31:00, NBIX is trading at $161.71 in after-hours trading, down 0.64% ($1.03) from the regular-session close of $162.74. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is NBIX stock trading now?
NBIX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does NBIX sit relative to its 52-week high and low?
Over the past 52 weeks, NBIX has traded between a low of $122.14 and a high of $186.12. At $162.74, the stock is positioned 63.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Neurocrine Biosciences Inc. in?
Neurocrine Biosciences Inc. (NBIX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Neurocrine Biosciences Inc.'s market capitalization and where is it listed?
Neurocrine Biosciences Inc. is listed on the NASDAQ exchange with a market capitalization of $16.73B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is NBIX valued in terms of P/E ratio and EPS?
NBIX trades at a P/E ratio of 23.91, based on trailing-twelve-month EPS of $6.94. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Neurocrine Biosciences Inc. pay a dividend?
Neurocrine Biosciences Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NBIX, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

NBIX Stock Calculator

Estimate the value between NBIX shares and USD.

NBIX Shares to USD

NBIX Shares
NBIX
NBIX
USD
USD
USD

1.00 NBIX shares = 162.74 USD

Calculations are estimates based on the latest available price and are for reference only.